Basiliximab: efficacy and safety evaluation in kidney transplantation.
about
Solid phase-based cross-matching as solution for kidney allograft recipients pretreated with therapeutic antibodies.Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipientsCytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.Renal association clinical practice guideline in post-operative care in the kidney transplant recipient
P2860
Basiliximab: efficacy and safety evaluation in kidney transplantation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Basiliximab: efficacy and safety evaluation in kidney transplantation.
@en
type
label
Basiliximab: efficacy and safety evaluation in kidney transplantation.
@en
prefLabel
Basiliximab: efficacy and safety evaluation in kidney transplantation.
@en
P2860
P1476
Basiliximab: efficacy and safety evaluation in kidney transplantation.
@en
P2093
Claudio Ponticelli
P2860
P304
P356
10.1517/14740338.2014.861816
P407
P577
2013-11-25T00:00:00Z